Advertisement

Hematology

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Podcasts Q&As
Interactive
Polls Quizzes
Events & Education
ASH Annual Meeting

FDA Alerts

Hematology
Hematology
FDA Approves First Treatment Option for Chronic Graft Versus Host Disease
08/02/2017
After results from a recent trial demonstrated its efficacy, the FDA expanded the indication of a cancer drug to include adult patients with chronic graft versus host disease who do not respond to other...
08/02/2017
Hematology
Hematology
New Treatment Option for Hemophilia Approved
06/01/2017
The US Food and Drug Administration recently approved a new treatment option for patients with hemophilia B.
06/01/2017
Hematology
Hematology
New Treatment Option for Hemophilia Approved
06/01/2017
The US Food and Drug Administration recently approved a new treatment option for patients with hemophilia B.
06/01/2017